Preparation and Optimization of Clotrimazole
Transdermal Gel of Nanosize Transfersome with Different Non-Ionic
Surfactant
Pallavi
Chavan, Kedar Bavaskar*, Rutuja Sawant , Dr. Ashish Jain
Department of Pharmaceutics, Shri. D.D. Vispute College of
Pharmacy and Research Centre, Panvel, Maharashtra, India
*Correspondence: cpallavi53@gmail.com
INTRODUCTION
A
major cause of skin illness in the world is fungus. About 40 million people in emerging
and underdeveloped countries have a fungal infection, according to reports. The
vast majority of the time, fungi penetrate the skin through the surface prior
to using desquamation to spread deeper into the skin. One of the fungi most
commonly responsible for superficial cutaneous infections is the Candida
species.1 Dermatophytes that can penetrate the stratum corneum and
keratinized tissues, such as Trichophyton, Microsporum, and Epidermophyton, are
the principal causes underlying skin fungal infections. Non-dermatophyte fungi
less frequently cause skin fungal infections.2 Cutaneous mycoses are
a type of fungal infection that manifests in the deeper layers of the skin. Dermatophytes
is a synonym for fungal skin diseases. The term "subcutaneous mycosis"
indicates a fungus infection that has already spread to deeper skin tissue.3
However, applying antifungal drugs topically may have unfavourable skin
side effects, like an allergic reaction and irritation. Standard formulations
also call for repeated administration of high doses, which raises the
possibility of local and systemic adverse effects.4 To Decrease
local side effects and improve the efficacy of treatment, a novel drug delivery
system is envisioned. Novel drug delivery system (NDDS) have created a lot of
attention in pharmaceutical research as one of the themes of topical
formulation .5 The fluidity and integrity of the fungal cell
membrane are probably maintained in part by ergosterol.
The
effective treatment of cutaneous dermatophytosis should include topical
antifungal formulations with high skin penetration. Azoles' antifungal efficacy
is connected to their capacity to prevent the formation of ergosterol.
Determined by factors such as particle size, surface charge, and lipophilicity,
penetration depth into various skin layers can be determined. To cure cutaneous
dermatophytosis, it is thought that negatively charged nanostructured lipid
carriers with sizes between 200 and 300 nm have a stronger penetration into the
deep skin layers.6 Novel topical formulation techniques include
solid-lipid nanoparticles, liposomes, niosomes, Transfersomes, microemulsions,
and nano emulsion appear to be more effective for penetrating the skin
permeability barrier.7
A broad-spectrum imidazole antifungal
medication called clotrimazole is mostly used to treat skin infections like
candidiasis. The BCS class (II) drug clotrimazole exhibits high permeability
and rate-limited release characteristics. Clotrimazole prevents the
proliferation of fungal cells by inhibiting the formation of ergosterol.
Transfersomes exhibit increased deformability as a result of edge activators
weakening their lipid bilayers. Due to
their greater deformability and ability to easily pass through holes that are 5
times smaller than their diameter, transfersomes have greater skin penetration
than ordinary liposomes. transfersomes
have been created to address the issue of release permeability and side
effects, avoiding the issue with conventional dosage forms and reducing the
side effects associated with antifungal medications like Clotrimazole.8 However,
increasing skin penetration too much runs the risk. after significant
penetration, medication molecules may enter the bloodstream and be bad for
treating skin fungal infections locally. 9
In 1991, Gregor Ceve created the
Transferosome. The complex system known as a transferosome is composed of an
ultra-deformable, highly flexible, stress-responsive composite lipid bilayer
surrounding the aqueous center.10 Transferosomes push against the
internal sealing lipid of the stratum corneum to penetrate the skin's barrier
to penetration. Transferosome membranes are flexible when the proper
combination of surface-active molecules is used in the proper ratios. There are
numerous ways to prepare transferosomes. For the preparation of transfersomes,
further techniques include reverse phase evaporation, rotary film evaporation,
modified hand shaking, vortex/sonication, freeze-thaw, and ethanol injection.11
Transferosomes penetrate the skin's barrier by breaking through the
internal sealing lipids of the stratum corneum. The mechanism for transfersome
penetration can be triggered by water evaporating as a lipid solution is
applied to the skin's surface. This results in the formation of an osmotic
gradient. Due to their high bilayer deformability, transfersomes have a greater
capacity for creating in and holding onto water.12 It penetrates the
skin barrier when applied to the non-occluded skin surface and hydrates the
deeper strata (an area rich in water).13 Transferosomes serve as
penetration enhancers by disrupting the tightly organized intercellular lipids
of the stratum corneum, allowing drug molecules to enter and pass through the
stratum corneum.14
The
purpose of this research was to create Clotrimazole transfersomes, which were
subsequently added to an appropriate hydrogel foundation for maximum drug
loading and improved penetration properties. Through the thin film hydration
approach, clotrimazole transfersomes were created utilizing phosphatidylcholine
and the edge activators tween 80 and span 60. Then, characteristics such as
drug entrapment, size, charge, morphology, and stability of the transfersomes
were determined. Carbopol 934 and Xanthan gum, two natural and artificial
gelling agents, were used in the formulation of the clotrimazole hydrogel.
Additionally, the drug concentration, pH, viscosity, in vitro release,
spreadability, extrudability, and in vitro antifungal efficacy of the
transfersomal hydrogel have been evaluated.
MATERIALS AND METHODS
Materials
Clotrimazole
was a gift sample from Jk Chemicals Valsad, Gujrat Soya Lecithin, Tween 80,
Span 60, Carbopol 934, and Xanthan gum were obtained from Research-Lab Fine
Chem Industries, Mumbai.
Ultraviolet-Visible (UV-Vis) Spectrophotometry
Preparation
of clotrimazole standard stock solution (in methanol). A 100 ml volumetric
flask had been loaded with 10 mg of Clotrimazole after it had been precisely
weighed. To create 100 g/ml of standard stock solution, it was dissolved and
diluted with solvent until the desired strength was reached. Scanners used
spectrophotometry to calculate the drug's maximum effective dose. 1 ml of
standard stock solution was pipette out and diluted up to 10 ml by using
suitable solvent and scanned between 200 nm and 400 nm in wavelength. 15,25
FT-IR Spectroscopy
The
interaction of the drugs and excipients could be determined by contrasting the
spectra. By using FTIR, the IR spectra of the pure drug (clotrimazole),
excipients, and mixtures of the two were recorded.
Preparation of Transfersomes by Thin
film hydration Method
The
thin film hydration methodology was used to develop transfersomal formulations
using clotrimazole, soy lecithin, span 60, and Tween 80. The organic solvent
Methanol was used to weigh out and completely dissolve the drug, phospholipid,
and surfactant. Using a rotary flash evaporator, the solvent was evaporated for
30 to 40 minutes at reduced pressure and 60 revolutions per minute. Dry After
the formation of the dry film, a transfersomal dispersion made up of
multi-lamellar vesicles was produced using PBS pH 7.4 and gentle shaking. The Prepared
vesicles were sonicated to create tiny vesicles at room temperature.16
Formulation batches of different ratios of drug and non-ionic surfactant are shown
in Table 01.
Characterization of Clotrimazole
transfersomes
Visual
inspection was done by putting the transfersomal dispersion in clear
containers, turbidity, flocculation, and sedimentation were examined. Using a
digital pH meter that had been previously calibrated by standard solutions with
pH of 4, 7, and 9.2, respectively.18
Entrapment efficiency
A
volume of 2 ml from each formulation was centrifuged using microcentrifugation
tubes at 10000 rpm for 20 min. The amount of free (unencapsulated) Clotrimazole
in the filtrate was measured using a UV spectrophotometer (Shimadzu®, Japan)
set to measure at 260 nm.19 The EE % was calculated by following
formula,
EE%= [total amount of drug added−free drug total amount of
drug added] ×100
Preparation of Transfersomal gel by dispersion method
The
gel base made with various concentrations of carbopol 934 was given the best
transfersome formulation to be added. Gelling agent was measured out and added
to the distilled water while being constantly stirred. It was irrigated for two
hours while being immersed. Propylene glycol (10% w/w), for example, was
continuously swabbed and mixed after the necessary amount of the optimum
transferosomes formulation was introduced. The gel was neutralized with
triethanolamine (TEA) to a pH range of 5 to 7, and the final weight adjusted by
adding water. The gel was left undisturbed for the remainder of the day after
being sonicated for 30 minutes on a bath sonicator to remove trapped air. 20,21
Preparation batches of Carbopol 934 and Xanthan gum transfersomal gel are shown
in Table 02.
Evaluation of Transfersomal gel
Spreadability
Glass
slides and wooden block measuring tools were used to determine it. An excess sample was put between two glass
slides to measure spreadability, and it was then compacted to a consistent
thickness. 50 grams of weight were put
into the pan. The spreadability (S) was
calculated as the time it took to move the upper glass slide across the bottom
plates or as the time it took to separate the two slides.
Extrudability
A
Pfizer hardness tester was used for the extrudability test. The metal tube was collapsible and contained
15g of gel. After adjusting the plunger to hold the tube securely, 1 kg/cm2 of
pressure was applied for 30 seconds. Weighing was done on the amount of gel
that was extruded.
Viscosity
A
Brookfield viscometer was used to measure the viscosity. Using a Brookfield
viscometer (Model DV2T) with T-94 Spindle, at ambient temperature (25–27°C),
viscosity measurements were made.
Drug content
In
100 ml of methanol, 1g of the formulation was sonicated for 30 minutes. The
syringe filter was then used to filter the solution. Spectrophotometric
analysis was used to assess the filtrate's drug content at 260 nm (UV-2450,
Shimadzu, Japan). 22,24
Drug release studies from transfersomal gel
To
study the rate at which the medication is released from the formulation, a set
of Franz diffusion cells were used in an in-vitro diffusion
investigation using Transfersomal gels. Receptor medium (PBS pH 7.4) was poured
into the receptor chamber. Throughout the experiment, the temperature of the
receptor medium was maintained at 37°C. A dialysis membrane was clamped between
two chambers after being soaked in receptor media for 12 hours. The donor cell
received 1g of the formulation. Then, after a set period of time, 1 ml samples
of the receptor cell were obtained. To keep the volume constant, an equal
amount of new medium was added after each collection. Fresh receptor media was
used as the blank for the spectrophotometric examination, and the extracted
samples were diluted as necessary. An equation created from standard
calibration was used to calculate the drug concentration delivered at a
specific time interval.22,24
Drug release kinetic modelling
The Results of in-vitro diffusion investigations
were fitted with several kinetics models to determine the release mechanism. Commonly used analytical
definitions of the Qt include the Higuchi-matrix, Peppas-Korsmeyer model,
zero-order definition, and first-order definition .22
In vitro antifungal
study
The tests were done on Candida albicans as the test
microorganisms to determine the biological activity of the Transfersomal
formulation in comparison to commercially available clotrimazole gel and plain
clotrimazole transfersomal gel. The 'Cup plate' method of an agar diffusion
test is used to determine this. In the Petri plates, a layer of Sabouraud's
dextrose agar media containing the test microorganisms was allowed to set up.
With the use of a sterile borer, cups were formed on the hardened agar layer.
One cup is filled with the Transfersomal gel solution (1% of the drug), and the
second cup is filled with commercialized gel (1% of the medication). 8,23
Stability study
According
to the International Council for Harmonization's (ICH) requirements, the
stability study of the formulation was completed. According to ICH rules,
freshly prepared formulations were separated into groups and stored under
specific conditions.22
RESULTS AND DISCUSSION
Ultraviolet-visible (UV-Vis) spectrophotometry
The
maximum absorbance (max) of the drug, clotrimazole, was identified to be the
peak with the greatest intensity in the UV-Vis spectrum analysis at 260 nm. The
value of R2 was found to be 0.999, indicating the relation between
Drug concentration and absorbance was linear in selected range.
FTIR Spectroscopy
By comparing the spectra, it was determined
whether the drug and excipients were compatible with each other. The IR spectra
of the pure drug and excipients as well as the mixture of drug and excipients
have been captured by using FTIR. The spectrum of pure Drug (Clotrimazole) Presented
characteristic Bands at 701.73,823,907.12 cm-1 for the Aromatic C-H
Bending group. For C-N stretching group peaks were noted on
1044.04,1078.28,1209.29 cm-1.for C=N stretching peak was noted on
1557.51 cm-1. Aromatic C-H stretching group type of vibration with
frequency 2886.81,3063.67 and 2978.09 cm-1. Aromatic C-Cl stretching
group type of vibration with frequency 633.27 and 667.50 cm-1.
The infrared spectra of the mixture of Soya Lecithin, a
Non-ionic surfactant (Tween 80 and Span 60) ingredient showed Peak at the C-O
group with frequency 1072 cm-1 and C=O group with frequency 1635.60 cm-1 and
1735 cm-1 which indicates Soya lecithin is present in Transfersome. Also, the
C-H group shows a peak of 2816.07 cm-1. The Hydroxyl group shows a peak of 3425.58
which indicates the presence of Tween 80. Carboxylic acid shows a peak on
2312.65 cm-1 and Aromatics Stretching group peaks are noted on 717.52 cm-1 and
879.54 cm-1, it indicates the presence of Span 60. For the C-N group peaks were
noted on 1072.42 cm-1 and 1211.30 cm-1.C-Cl group shows a peak on 725.23,1559.91
and 694.37 cm-1 which indicate the presence of the Drug in Transfersomes which
shown in Figure 2.
The IR spectrum of Polymer (Carbopol 934) showed characteristic
peaks at 1172.72 and 1234.44 cm-1 for group C-O. for Group C=O peak showed at
1699.29 cm-1 .C-H stretching showed peak on 2945.30 cm-1. In the case of Final
gel formulation, Infrared spectra of the mixture of Clotrimazole, transfersome,
and polymer (Carbopol 934) showed similar characteristic peaks at the
appropriate wavelengths, indicating Clotrimazole’s compatibility with different
excipients. The IR spectrum of xanthan Gum as a polymer showed characteristic
peaks at 3803.63 and 3302.13 cm-1 for group O-H. The peaks for group C=O showed
peaks on 1717.12 cm-1. -COO group shows a frequency of 1419.61 cm-1. The
Carboxyl group shows peaks on 1111.60 cm-1 and B glycoside showed frequency on
702.09 and 725.23 cm-1. The IR spectrum of Final Gel formulation showed similar
peaks to Clotrimazole, Transfersomes, and xanthan gum so it indicates
compatibility with each other by increasing its frequency shown in figure 3.
Entrapment efficiency
Clotrimazole
transfersomal dispersion was prepared with different ratios by using soya
lecithin and two different non-ionic surfactants (Tween 80 and span 60). based
on Entrapment efficiency F1 batch was selected as the optimized batch. According
to figure 4, F1 formulation with a ratio of 90:10 shows
the greatest entrapment efficiency .it shows 91.91%. so, it concluded that Span
60 shows better Entrapment efficiency than Tween 80 in Figure 4.
Tween 80 (water-soluble surfactant) showed
Lower drug entrapment within transfersome vesicles as compared to Span 60 because
of the HLB value. The Tween HLB value is 15 and the Span HLB value is 4.7.
Higher the HLB value lower the entrapment efficiency in the case of
Transfersomes. Formulation F1 (91.91%) has a higher entrapment effectiveness
due to the fact that is a greater concentration of phospholipid available for
coating an aqueous volume. because of the higher Span 60 surfactant content,
which causes micelle formation as well as less effective trapping.
Zeta potential and Polydispersity index
Zeta potential was revealed by particle
size analysis, and the optimized batch's PDI was found to be 0.314 with an
average size of 62.87 nm. The particles were homogeneously distributed and of
uniform size, as evidenced by the decreased polydispersity. Transfersomes with
Clotrimazole loaded had a surface charge of -25.8 mV, according to measurements.
The graph of Zeta potential and PDI is shown in figure 5a and 5b.
Electronic microscopy
A transmission electron microscopy study was done of optimized
clotrimazole transfersome batch F1. It displays the general shape and interior
of the recognized spherical vesicles. The average size of the Transfersome was
found to be 61 nm. TEM images display in figure 6
Evaluation of Clotrimazole Transfersomal
gel
Xanthan
gum and carbopol 934, the synthetic and natural polymers with varying
quantities that are listed in Table 02, were used to create transfersomal gel.
Tables 03 and 04 present the results of all the metrics used to evaluate
Transfersomal gels, including homogeneity, pH, viscosity, spreadability,
extrudability, and drug content uniformity.
Better
extrudability is shown by more Transfersomal gel being extruded in a given
amount. 1% Carbopol gel and 1% Xanthan Gum gel were shown to have superior
extrudability than other formulations. Both formulations demonstrated excellent
extrudability. Carbopol 934 was considered to have excellent spreadability
since it spread over a shorter period of time than xanthan Gum at all
concentrations. The effectiveness of gels as a treatment depends on how they
are applied. Because it helps with the consistent distribution of the gel to
the skin, the created gels must be easily spreadable and fulfil the perfect
specifications for transdermal application. This is also considered to be a
crucial component of patient adherence to medication.
The
drug content of Carbopol transfersomal gel is better than the xanthan gum
transfersomal gel. Carbopol 1% gel shows 90.86 % while 1% xanthan gum gel shows
85.96%. so, it concludes that Synthetic polymer shows better drug content than
Natural polymer. Carbopol 934 gel shows low viscosity than xanthan gum gel. Viscosity
also increases as the gelling agent concentration increases. The viscosity of
gel compositions often reflects uniformity.
This
behavior was chosen because, in high-shear circumstances, it has a low flow
resistance. These gels become less viscous as the rate of shear increases, as
demonstrated by non-Newtonian flow (shear thinning). the ability to spread
widely due to a drop in viscosity caused by the application of a given force,
while also maintaining its location at the application site without
draining. so, carbopol 934 Transfersomal
gel showed the best evaluation result than xanthan gum transfersomal gel.
In vitro Diffusion study
A
diffusion study was also conducted between 1% carbopol gel, 1% xanthan gum gel,
and 1 % Canesten® cream (marketed product). A 24-hour in vitro drug
release investigation was carried out. In
vitro drug release of transfersomal gel batches
was examined in Phosphate Buffer solution with pH 7.4, as clotrimazole is a
weak acid by nature and enters into the bloodstream in unionized form.
Diffusion studies were conducted for 24-hour.
The maximum drug release was seen with
the 1% carbopol 934 clotrimazole transfersomal gel because it allowed the drug
to be released more gradually and for a longer period of time than the other
two products.
In Vitro
Antifungal study
The
anti-fungal efficacy of 1% Canesten® cream (standard) and 1% clotrimazole
transfersomal gel (test) against Candida albicans was compared using the
cup plate method. A response from zone of inhibition was interpreted as the
comparison of standard and test preparations. Figure 8 showed the results for
the zone of inhibition, and it was clear that 33mm zone of inhibition for the
1% Clotrimazole Transfersomal gel shown large zone of inhibition than 26mm zone
for the 1% Canesten® cream. The ability of the Transfersome to get through the
fungal cell wall and limit ergosterol biosynthesis, which in turn led to cell
death and membrane lysis, may have contributed to this variation in the zone of
inhibition. Picture of Zone of inhibition shown in figure 8.
Drug release kinetic model
According
to the findings of our kinetics investigation, Prepared batches were best
suited in the Zero order release kinetic model, which had the greatest R2
value of all the kinetic models. Among all the formulations suggested as having
the greatest fit for zero order kinetics, F4TG4 demonstrated the highest R2
value. It means that the medicine is released from the transfersomal gel at a
constant rate per unit of time. Table 6 displays R2 values.
CONCLUSIONS
In the present research, soya lecithin, non-ionic surfactant
Tween 80, and span 60 were combined in different ratios to formulate
transfersomes. The entrapment efficiency of the prepared transfersomes ranged
from 91.91% to 50.9%, and they were negatively charged, nanosized vesicles (61
nm) in size. Due to span 60's low HLB value, span 60 exhibits the best
entrapment efficiency. It concluded that among all formulations 1% carbopol 934
as a synthetic polymer shows better results than 1% Xanthan gum natural
polymer. so, we can conclude that carbopol 934 is the best gelling agent for the
preparation of transfersomal gel. as it shows better drug release as compared
to the other two formulations. According to our research, the
Transfersomal Formulation provided a sustained and prolonged pharmaceutical
delivery with improved patient compliance and enhanced bioavailability. The
transfersomal formulation's transdermal delivery method may be a useful dosage
form for reducing the unfavorable effects of the oral delivery method. The
preparation process is straightforward and practical from an industrial
standpoint. Transfersomes may therefore be thought of as an efficient means of
delivering clotrimazole via the transdermal route to treat deeper-layer fungal
skin infections.
ACKNOWLEDGEMENTS
We appreciate the excellent guidance provided by
Dr. Ashish Jain, the principal of Shri. D.D. Vispute college of Pharmacy and
Research center. We also want to express our gratitude to Mr. Kedar Bavaskar
for his help. A special thanks goes out to JK Chemicals Valsad, Gujarat for
supplying the Clotrimazole sample as a gift. The authors also expressed
gratitude to Mumbai's Research-Lab Fine Chem Industries for offering a variety
of excipients
REFERENCES
1.
Havlickova B, Czaika VA, Friedrich M.
Epidemiological trends in skin mycoses worldwide. Mycoses. 2008; 51:2–15.
DOI: 10.1111/j.1439-0507.2008.01606.
2. Kannan P,
Janaki C, Selvi GS. Prevalence of dermatophytes and other fungal agents
isolated from clinical samples. Indian J Med Microbiol. 2006;24(3):212–5.
3. Adams BB.
Tinea corporis gladiatorum. J Am Acad Dermatol. 2002;47(2):286–90.DOI:
https://doi.org/10.1067/mjd.2002.120603
4.
Naik A, Kalia YN, Guy RH. Transdermal drug
delivery: overcoming the skin's barrier function. Pharm Sci Technol.
2000;3(9):318–26. DOI: 10.1016/s1461-5347(00)00295-9
5.
Lorand T, Kocsis B. Recent advances in antifungal
agents. Mini Rev Med Chem. 2007;7(9):900–11. DOI: 10.2174/138955707781662672
6. Massa N,
Cantamessa S, Novello G, Ranzato E, Martinotti S, Pavan M, et al. Antifungal
activity of essential oils against azole-resistant and azole-susceptible
vaginal Candida glabrata strains. Can J Microbiol. 2018;64(10):647–63.
DOI: 10.1139/cjm-2018-0082
7. Guy RH.
Pharm Res. 1996;13(12):1765–9. DOI: 10.4103/jphi.JPHI_35_16
8. Singh S,
Kanere M, Jain A, Mehta P. Formulation development and evaluation of
transfersomes of econazole for effective fungal treatment. J Adv Sci Res.
2021;12(03 Suppl 1):96–101.DOI:10.55218/JASR.s1202112310
9. Verma S,
Utreja P. Vesicular nanocarrier based treatment of skin fungal infections:
Potential and emerging trends in nanoscale pharmacotherapy. Asian J Pharm Sci.
2019;14(2):117–29.DOI: 10.1016/j.ajps.2018.05.007
10. Chauhan
P, Tyagi BK. Herbal novel drug delivery systems and transfersomes. J Drug Deliv
Ther. 2018;8(3). DOI: 10.22270/jddt.v8i3.1772
11. Cevc G,
Blume G. Lipid vesicles penetrate intact skin owing to the transdermal osmotic
gradients and hydration force. Biochim Biophys Acta Biomembr.
1992;1104(1):226–32.
DOI: 10.1016/0005-2736(92)90154-e
12. Jain S,
Jain P, Umamaheshwari RB, Jain NK. Transfersomes-a Novel Vesicular Carrier for
Enhanced Transdermal Delivery: Development, Characterization, and Performance
Evaluation. Drug Development and Industrial Pharmacy. 2003;29(9):1013–26. DOI: 10.1081/ddc-120025458
13. Maurya
SD, Agarwal S, Tilak VK, Dhakar RC, Singh A, Maurya G. Enhanced transdermal
delivery of indinavir Sulfate via transferosomes. Int J Compr Pharm. 2010;
1:1–7.
14. Singh S,
Parashar P, Kanoujia J, Singh I, Saha S, Saraf SA. Transdermal potential and
anti-gout efficacy of Febuxostat from niosomal gel. J Drug Deliv Sci Technol.
2017; 39:348–61. DOI:10.1016/J.JDDST.2017.04.020
15. Opatha
SAT, Titapiwatanakun V, Boonpisutiinant K, Chutoprapat R. Preparation,
characterization and permeation study of topical gel loaded with transfersomes
containing Asiatic acid. Molecules. 2022;27(15):4865. DOI: 10.3390/molecules27154865
16. Cevc G,
Blume G, Schätzlein A. Transfersomes-mediated transepidermal delivery improves
the regio-specificity and biological activity of corticosteroids in
vivo1Dedicated to the late Dr. Henri Ernest Bodde.1. J Control Release
.1997;45(3):211–26. DOI:10.1517/17425247.3.6.727
17. Khan MA,
Pandit J, Sultana Y, Sultana S, Ali A, Aqil M, et al. Novel Carbopol-Based
Transfersomal Gel of 5-Fluorouracil for Skin Cancer Treatment: in Vitro
characterization And in Vivo study. Drug Delivery. 2014;22(6):795–802. DOI: 10.3109/10717544.2014.902146
18. Qushawy
M, Nasr A, Abd-Alhaseeb M, Swidan S. Design, optimization and characterization
of a transfersomal gel using miconazole nitrate for the treatment of candida
skin infections. Pharmaceutics.2018;10(1):26. DOI: 10.3390/pharmaceutics10010026
19. Ahad A,
Al-Saleh AA, Al-Mohizea AM, Al-Jenoobi FI, Raish M, Yassin AEB, et al.
Pharmacodynamic study of eprosartan mesylate-loaded transfersomes Carbopol® gel
under Dermaroller® on rats with methylprednisolone acetate-induced
hypertension. Biomed Pharmacother. 2017; 89:177–84. DOI: 10.1016/j.biopha.2017.01.164
20. Shinde
UA, Kanojiya SS. Serratiopeptidase niosomal gel with potential in topical
delivery. J Pharm (Cairo).2014; 2014:382959. DOI: 10.1155/2014/382959
21. Benson
HAE. Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv.
2006;3(6):727–37. DOI: 10.1517/17425247.3.6.727
22. Taymouri
S, Hajhashemi V, Tabbakhian M, Torkashvand M. Preparation and evaluation of
imatinib loaded transfersomal gel for the treatment of rheumatoid arthritis.
Iran J Pharm Res. 2021 Autumn;20(4):33–46. Doi:10.22037/ijpr.2021.115481.15394
23. Al-Ibraheem
SAH. In-vitro Activity of Essential Oils Extracted from Thymus vulgaris
and Origanum vulgare against Candida albicans. International
Journal of Drug Delivery Technology. 2021;11(3):690-695. DOI:
10.25258/ijddt.11.3.7
24. Alwan
LA, Al-Akkam EJ. Formulation and Evaluation of Transdermal Dissolved
Microneedles Patches for Meloxicam. International Journal of Drug Delivery
Technology. 2021;11(3):656-662. DOI: 10.25258/ijddt.11.3.2
25. Sanganabhatla,
D. and Sunder, R.S. (2019). Development and Validation of UV Spectrophotometric
Method for The Estimation of Finasteride Drug. International Journal of
Pharmaceutical Quality Assurance 10(4): 597-600. DOI:
10.25258/ijpqa.10.4.6
Table 01. Formulation batches of clotrimazole transfersome.
|
Formula code
|
Drug
|
Soya lecithin: Span 60
|
Soya lecithin: Tween 80
|
|
F1
F2
F3
F4
F5
F6
F7
F8
|
100 mg
100 mg
100 mg
100 mg
100 mg
100 mg
100 mg
100 mg
|
90:10
85:15
80:20
75:25
-
-
-
-
|
-
-
-
-
90:10
85:15
80:20
75:25
|
Table 02: Batches for preparation of Clotrimazole transfersomal
transdermal gel using Carbopol 934 and Xanthan gum
|
Batches
|
F1CG1
|
F1CG2
|
F1CG3
|
F1CG4
|
F1XG1
|
F1XG2
|
F1XG3
|
F1XG4
|
|
Transfersomal
dispersion
|
1%
|
1%
|
1%
|
1%
|
1%
|
1%
|
1%
|
1%
|
|
Carbopol
934
|
0.5 %
|
1%
|
1.5%
|
2%
|
-
|
-
|
-
|
-
|
|
Xanthan
gum
|
-
|
-
|
-
|
-
|
0.5
%
|
1%
|
1.5%
|
2%
|
|
Propylene
glycol
|
10%
|
10%
|
10%
|
10%
|
10%
|
10%
|
10%
|
10%
|
|
Glycerine
|
30%
|
30%
|
30%
|
30%
|
30%
|
30%
|
30%
|
30%
|
|
Triethanolamine
|
Q. S
|
Q. S
|
Q. S
|
Q. S
|
Q. S
|
Q. S
|
Q. S
|
Q. S
|
|
Transfersomal
Gel
|
Carbopol 934
|
|
Sr No.
|
Evaluation
parameters
|
F1CG1
(0.5%)
|
F1CG2
(1%)
|
F1CG3
(1.5%)
|
F1CG4
(2%)
|
|
1.
|
Homogeneity
|
++
|
+++
|
+++
|
-
|
|
2.
|
pH
|
6.83±0.27
|
7.02±0.11
|
7.09±0.02
|
6.45±0.45
|
|
3.
|
Spreadability
(g.cm/sec)
|
17.90±0.23
|
16±0.14
|
12±1.12
|
10±3.45
|
|
4.
|
Extrudability
(%)
|
93±0.41
|
95±0.75
|
90±0.30
|
86±0.87
|
|
5.
|
Viscosity (cP)
|
25,748
|
26,330
|
27,126
|
30,012
|
|
6.
|
% Drug content
|
85.98
|
90.86
|
88.65
|
87.05
|
|
Values are average of three readings ±
standard deviation
|
Table 03. Evaluation of Carbopol
934 transfersomal gel
|
Transfersomal
Gel
|
Xanthan gum
|
|
Sr No.
|
Evaluation parameters
|
F1XG1
(0.5%)
|
F1XG2
(1%)
|
F1XG3
(1.5%)
|
F1XG4
(2%)
|
|
1.
|
Homogeneity
|
+
|
++
|
+
|
+
|
|
2.
|
pH
|
6.72±0.09
|
7.09±0.03
|
7.11±0.01
|
6.97±1.20
|
|
3.
|
Spreadability
(g.cm/sec)
|
40.20±2.90
|
32.72±3.40
|
28±3.48
|
21±0.97
|
|
4.
|
Extrudability (%)
|
85±0.65
|
94±0.87
|
90±0.40
|
80±0.72
|
|
5.
|
Viscosity (cP)
|
10,542
|
12,320
|
14,548
|
18,580
|
|
6.
|
% Drug content
|
81.25
|
85.96
|
84.89
|
83.74
|
|
Values are average of three readings ±
standard deviation
|
Table 04. Evaluation of xanthan gum transfersomal gel
Table 05. In vitro
drug release of clotrimazole Transfersomal gel and marketed product
|
Time (Hr)
|
Drug diffused from the Formulation (%)
|
|
|
|
1% Carbopol gel
|
1
% Xanthan gum
|
1%
Marketed formulation
|
|
0
|
2.18
|
0.97
|
0.81
|
|
1
|
13.42
|
12.84
|
9.84
|
|
2
|
17.82
|
17.49
|
14.45
|
|
4
|
21.94
|
27.84
|
25.78
|
|
6
|
37.56
|
36.75
|
34.88
|
|
8
|
43.98
|
41.94
|
41.54
|
|
10
|
53.87
|
52.86
|
50.15
|
|
12
|
67.22
|
63.87
|
62.85
|
|
16
|
77.59
|
80.74
|
78.94
|
|
24
|
91.64
|
87.94
|
90.04
|
Table 06. R2 values of drug release kinetic model of
different formulations
|
Formulation
Kinetic Model
|
1% Carbopol gel
|
1%
Xanthan gum
|
1% marketed formulation
|
|
Zero order
model
|
0.9689
|
0.9604
|
0.9570
|
|
First order
model
|
0.9062
|
0.8938
|
0.8851
|
|
Higuchi model
|
0.9574
|
0.957
|
0.9474
|
|
Korsmeyer- peppas
model
|
0.7426
|
0.7414
|
0.7889
|
|
Hixon-Crowell model
|
0.9291
|
0.9125
|
0.9102
|
Figure
1: Represents The Uv-vis Spectra of clotrimazole in methanol. The
peak with greatest intensity in Uv vis spectrum analysis at 260 nm
Figure 2: Describes the FTIR of Transfersomal suspension with Drug and
Excipients and final formulation of Transfersomal gel (Carbopol 934). Infrared
spectra of the mixture of Clotrimazole, transfersome, and polymer (Carbopol
934) showed similar characteristic peaks at the appropriate wavelengths,
indicating Clotrimazole’s compatibility with different excipients.
Figure 3: Describes the FTIR of Transfersomal suspension with Drug and
Excipients and final formulation of Transfersomal gel (Xanthan gum). Infrared
spectra of the mixture of Clotrimazole, transfersome, and polymer showed
similar characteristic peaks at the appropriate wavelengths, indicating
Clotrimazole’s compatibility with different excipients.
Figure 4: The figure shows entrapment efficiency of clotrimazole
Transfersome in two different non-ionic surfactants like Tween 80 and Span 60.
Figure 5: a) Represents The polydispersity index of Clotrimazole
containing transfersomes.
b) Represents Zeta potential of clotrimazole containing
transfersomes.
Figure 6: The above image shows Transmission electron microscopy of
Transfersomes.
Figure
7: Represents In vitro Drug release of clotrimazole
Transfersomal gel and marketed product up to 24 hrs. by using Franz cell
diffusion apparatus
Figure 8: Shows In Vitro
Antifungal study Clotrimazole containing Transfersomal gel and 1% Canesten® cream against Candida albicans
using the cup plate technique